Secondary Fracture Prevention: An International Perspective presents practitioners and academic clinicians with a better understanding of secondary fracture prevention and models of care from a variety of settings and countries. This must-have guide provides practitioners and academic clinicians with essential information about this broad clinical and research topic that extends across the globe. Preventing secondary fractures starts with assessing what works and what does not work, reviewing major society guidelines, and what workup and management is necessary. This book reviews these topics and provides the rationale for pursuing a workup to prevent fractures in this patient population.
- Provides an international perspective, giving health professionals in different parts of the world essential information to establish country-specific, secondary fracture prevention programs
- Summarizes existing literature on secondary fractures and includes a description of the risks and how they can be prevented
- Highlights secondary fracture prevention and models of care
Biomedical researchers, research clinicians, clinicians and other health professionals concerned with osteoporosis
1. Introduction: Why secondary fracture prevention?
2. The risk of osteoporotic refracture
3. Models of Secondary Fracture Prevention: Systematic Review and Meta-analysis of Outcomes
4. International models of secondary fracture prevention
Secondary fracture prevention in Japan
Fracture Liaison Services in South East Asia: Notes from a large public hospital in Singapore
Secondary fracture prevention in Taiwan
Secondary fracture prevention in France
Secondary fracture prevention in the UK
Secondary fracture prevention in Brazil
Secondary Fracture Prevention in Lebanon
Fracture Liaison Services – Canada
Fracture Liaison Service: USA Perspective
Fracture Liaison Services: An Australasian Perspective
5. National and International Programs/Useful resources
- No. of pages:
- © Academic Press 2019
- 1st November 2018
- Academic Press
- Paperback ISBN:
Markus J. Seibel completed a medical degree and a doctoral degree in 1984 from the University of Mainz, Germany and the University of Pennsylvania, Philadelphia. Since 1996, he has been the head of the Endocrine Laboratories at Heidelberg University, Germany and a consultant in Endocrinology. Since 1997, he has been an Associate Professor and Member of the Faculty of Medicine at the University of Heidelberg and as of 1999, he will be Associate to the Director of the Department of Endocrinology and Metabolism. His research interests include bone and cartilage metabolism, treatment of osteoporosis, and thyroid carcinoma.
Concord Hospital, University of Sydney, Australia; Director, Department of Endocrinology and Metabolism, Concord Hospital Medical Center; Professor and Chair of Endocrinology, The University of Sydney
Dr. Mitchell is the Managing Director at Synthesis Medical NZ Limited. His primary goal is to improve management of chronic disease by closing care gaps through systematic implementation of evidence-based practice.
Dr. Mitchell has spent the last decade developing policy, guidelines and systematic approaches to hip fracture care and prevention throughout the world. He spent the previous 15 years working in the pharmaceutical industry, initially as a basic researcher in neuroscience and, subsequently, in sales, marketing and osteoporosis service development roles.
Specialties: Systems-based approaches to chronic disease management, osteoporosis, fragility fracture prevention, orthogeriatrics, fracture registries, dementia care, policy development, literature review, medical education, website content development.
Managing Director, Synthesis Medical NZ Limited, UK